exon 8 giving rise to a premature, in frame TAA stop codon, and a deletion of at least two exons from the 3' end of the gene.
In this paper we present evidence that a homozygous G-sA transition in the first position of the 5' splice site of intron 5 of FUCAI is the disease causing mutation in a 9 year old child of distantly related parents. A new banding pattern was detected in the patient by Southern blotting of genomic DNA using TaqI restriction and a cDNA FUCAI probe. The patient was homozygous for this pattern.
Three sibs with i-fucosidase activity below the normal reference range and both parents were heterozygous. This pattern was not detected in 26 other fucosidosis patients and has not been found in any controls. The mutation was localised by a combination of restriction mapping using different cDNA probes, single stranded conformational polymorphism analysis of exons and flanking regions amplified by the polymerase chain reaction, and by direct sequencing of the amplified sequence. In view of the nature of the mutation, its cosegregation with the disease mutation and its absence in con- cII or EcoRI to generate fragments A, B, and C ( fig 1) . The fragments were separated by electrophoresis in agarose and the DNA extracted from the agarose using 'Geneclean' (BIO 101). The probes were generated by labelling the fragments by the random hexanucleotide procedure12 using [a-32P] dCTP (Amersham International).
SOUTHERN BLOT ANALYSIS
Genomic DNA was isolated from peripheral blood leucocytes by using the guanidinium chloride extraction procedure.'3 DNA (10 jig) from members of the index family, 25 controls, and 26 other unrelated fucosidosis patients was digested with TaqI, BglI, or EcoRI restriction endonuclease according to the manufacturer's instructions. The resulting fragments were separated on an 0 8 to 1 % agarose gel and transferred to a nylon membrane by standard procedures.'4 The blots were then hybridised with the radiolabelled ox-fucosidase cDNA probes. Prehybridisation and hybridisations were carried out in 10 x Denhardt's solution, containing 4 x SSC, 50 jg/ml denatured salmon sperm DNA, and 1% (w/v) sodium dodecyl sulphate (SDS) for 16 hours at 65'C. Filters were washed twice for 20 minutes at room temperature in 3 x SSC containing 0-1% (w/v) SDS. This was followed by a higher stringency wash at 65'C for 30 minutes in 0-5 x SSC containing 0-1% (w/v) SDS. The membrane was wrapped in 'cling film' and placed in an x ray cassette with Kodak Xeromat film for 24 hours to a week.
POLYMERASE CHAIN REACTION (PCR) ANALYSIS
Exons 5 and 6 and their flanking regions were amplified by PCR using the primers in the table and fig 2. The primers were synthesised on an Applied Biosystems 38 1A DNA synthesiser, using DMT-biotin-C6-PA for primer 5 (Cambridge Research Biochemicals Ltd, Northwich, Cheshire, UK), according to the manufacturer's instructions. Genomic DNA (500 ng) in a total volume of 100 p1 was denatured at 94'C for 10 minutes, after which 2-5 units of Taq polymerase (Promega) were added and the mixture was held at 54'C for five minutes. This was followed by 30 cycles of one minute at 72'C, one minute at 94'C, and 30 seconds at 54'C. The amplified DNA was analysed by electrophoresis on a 1-5% agarose gel and visualised by staining with ethidium bromide; 20 p1 of amplified product was digested with TaqI according to the manufacturer's instructions (NBL, Framlington, Northumberland, UK) and analysed by electrophoresis on a 2% agarose gel followed by staining with ethidium bromide.
SINGLE STRANDED CONFORMATIONAL POLYMORPHISM (SSCP)'5 ANALYSIS Exons 5 and 6 and the exon 5/intron 5 boundary of the a-fucosidase gene were amplified by PCR using the primers and conditions already described. The reaction was carried out in a fig 3. y 6% No activity could be detected in the patient con-(SB) consistent with the diagnosis of fucosidocar-sis. Both parents had levels of activity at the and lower end of the control reference range, and x ray three of the five sibs had activity lower than normal. Another sib, SaB, had similar activity to her parents and one sib, DB, had normal activity.
,K using prlmers ) and 6 (table, ng Z) SOUTHERN BLOT ANALYSIS the conditions already described. The Genomic DNA was extracted from white on was carried out in a volume of 100 p1 blood cells of SB, digested with four different ining 5 pmol of each primer, 2 mmol/l restriction endonucleases, and analysed by 's, reaction buffer (Promega), and 500 ng Southern blotting using probes A, A + B, B, ient DNA. Fifty ptl of the amplified pro-and C. No abnormalities were seen after digesvas mixed with 30 p1 of magnetic Dynal tion with BglII, EcoRI, or PvuII. The normal 0 streptavidin beads (Dynal, UK) and pattern obtained with EcoRI excludes both the ated at room temperature for five mutation obliterating an EcoRI site in exon 8"8 -es and then placed in a magnetic rack. and the deletion at the 3' end, which is characbeads with the bound double stranded terised by an extra junction fragment of 12 kb.2 fied product were then incubated with SB was homozygous for the 120 kb allele of nol/l NaOH for five minutes to produce the BglII RFLP and the 7 0 kb allele of the stranded molecules. The biotinylated PvuII RFLP (haplotype 1-1 (fig 2) and analysing the amplified molecules for sequence differences. the patient's sibs were heterozygous for this TaqI restriction pattern. The sib DB, who had the highest activity, and the sib SaB, whose activity was similar to that of her parents, were not heterozygous for the TaqI polymorphism.
ANALYSIS OF EXON 6
Primers complementary to 5' and 3' intronic sequences flanking exon 6 (primers 1 and 2 in the table and fig 2) were used to prepare amplified DNA from SB and a control. Both amplification products failed to cut with TaqI, indicating that the new TaqI site in SB is not in exon 6 . Further evidence that a new TaqI site or another sequence change was not present in exon 6 of SB was obtained by SSCP analysis of the amplified products from SB and controls ( fig 5A) . Confirmation of the identity of the sequences of exon 6 and its flanking regions in SB and controls was obtained by direct sequencing of the amplified products and comparison with the published sequence.
LOCALISATION OF THE NEW TaqI RESTRICTION

SITE
The sequence change producing the new TaqI site appears to be associated with an allele causing a deficiency of a-fucosidase. The new TaqI site results in the loss of a 5-0 kb band and the generation of a new 1 8 kb band. It was not possible to localise the new TaqI site by direct restriction mapping because the sizes of some of the intronic sequences are not known. However, it was possible to deduce which section of the gene corresponded to the 5 kb fragment by the use of probes that cover different regions of the cDNA sequence and knowledge of the sequence. The new TaqI site was not observed after hybridisation with probe A which covers exons 1, 2, and part of 3, indicating that it is not in this region of the gene. The 54 kb TaqI band is much less intense than other bands when probe B is used for hybridisation but of comparable intensity when probe A+ B is used. The HincII site separating probes A and B is in exon 3, 5 bp upstream from the 3' end of exon 3 (fig 1) . This suggests that the 5-4 kb fragment spans exon 3. The 5-4 kb fragment is unaffected in patient SB, thereby excluding exon 3 as the location of ANALYSIS OF EXON 5 DNA from the patient and controls was amplified using primers specific for the 5' and 3' ends of exon 5 (primers 3 and 4 in the table and fig 2) . There are no TaqI sites in the 5' and 3' ends of exon 5 covered by the primers, according to the published sequence. The amplified material from both sources consistently failed to be cut by TaqI, suggesting that the new TaqI site was not in exon 5. SSCP analysis of amplified exon 5 from SB and controls also indicated that the sequence of exon 5 was the same in the patient and controls. This was confirmed by direct sequencing of the amplified products.
ANALYSIS OF INTRON 5
To amplify across the 5' splice site of intron 5, primers were synthesised specific for the middle of exon 5 and a sequence in intron 5 (primers 5 and 6 in the table and fig 2) , which should result in a 269 bp product. The amplified product from controls did not cut with TaqI, whereas the product from SB was cut into two unequal fragments ( fig 6) . As 
